ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Colorectal Cancer (ISSN: 1758-194X)

PublisherFuture Science Group




IF(Impact Factor)2018 Evaluation Pending



Colorectal cancer is a major cause of morbidity and mortality, particularly in the developed world. Risk factors for colorectal cancer are on the rise in many countries; populations are aging, and obesity and diabetes are increasing. National screening programs are helping to detect cancer while it is still curable; however, colorectal cancer remains the third leading cause of cancer deaths in the USA and options are still limited for those with more advanced disease. Consequently, colorectal cancer is a major research priority for government, pharmaceutical companies and non-profit organizations. Research into diagnosis and optimum treatment of the disease is progressing rapidly, with new advances reported every day. Colorectal Cancer presents reviews, analysis and commentary. on all aspects of colorectal cancer.
Colorectal Cancer provides a concise, readable overview of current and future management options in a fast-moving field, ideal for the busy clinician or healthcare professional.
Each issue will provide high-quality Reviews of current and emerging topics, cutting-edge Editorials discussing contentious issues and independent Drug Evaluations assessing individual medicines and their role in current treatment practices. In addition, forward-looking Perspectives and Interviews will give leading experts the opportunity to present criticism or address controversy. The journal will also provide a disease-specific forum for Case Studies and Original Research Articles reporting new clinical findings.
Coverage includes:
Risk factors and prevention
Hereditary nonpolyposis colorectal cancer and other hereditary conditions causing colorectal cancer
Biomarkers for screening
Colonoscopy and sigmoidoscopy for screening and diagnosis
Radiation therapy
Optimum chemotherapy regimes to maximize efficacy and minimize side effects
Monoclonal antibodies
Multimodality treatment
Prospects for new treatments, such as vaccines
Treatment of metastases
Follow-up care for colorectal cancer survivors

Last modified: 2017-08-06 12:09:13


  • No Archives